Bluejay diagnostics announces reverse stock split

Acton, mass., nov. 13, 2024 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, today announced that the company's board of directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-50 (the “reverse stock split”). the reverse stock split will become effective at 12:01 a.m. eastern time on november 18, 2024, and the company's common stock will open for trading on the nasdaq capital market on a post-split basis on november 18, 2024 under the company's existing trading symbol, “bjdx.” at such time, the company's common stock will also commence trading with a new cusip number, 095633509.
BJDX Ratings Summary
BJDX Quant Ranking